Charge Detection Mass Spectrometry (CDMS) for the characterization of recombinant adeno associated virus (rAAV) at different manufacturing stages
CDMS is reshaping the characterization of complex biotherapeutics by enabling precise analysis of large, heterogeneous biomolecular complexes and gene therapy vectors.